Wilkins, C.A.; Hamman, H.; Hamman, J.H.; Steenekamp, J.H.
Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features. Pharmaceutics 2024, 16, 178.
https://doi.org/10.3390/pharmaceutics16020178
AMA Style
Wilkins CA, Hamman H, Hamman JH, Steenekamp JH.
Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features. Pharmaceutics. 2024; 16(2):178.
https://doi.org/10.3390/pharmaceutics16020178
Chicago/Turabian Style
Wilkins, Christi A., Hannlie Hamman, Josias H. Hamman, and Jan H. Steenekamp.
2024. "Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features" Pharmaceutics 16, no. 2: 178.
https://doi.org/10.3390/pharmaceutics16020178
APA Style
Wilkins, C. A., Hamman, H., Hamman, J. H., & Steenekamp, J. H.
(2024). Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features. Pharmaceutics, 16(2), 178.
https://doi.org/10.3390/pharmaceutics16020178